68Ga-PSMA-R2
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for 68Ga-PSMA-R2, covering 2020-11-17 to 2020-11-17. Get the full timeline:
Most recent: Clinical Trial Update: 68Ga-PSMA-R2 in Patients With Biochemical Relapse (BR) and Metastatic Prostate Cancer (mPCa) [Phase 1, Phase 2]